Skip to content
PeptidePlotter logo PeptidePlotter
Search (no-JS fallback)

Peptides

Melatonin

Also called N-acetyl-5-methoxytryptamine

Melatonin is used to help with sleep timing and some sleep problems. It is not simply a stronger-is-better sedative: when it is taken and whether it releases quickly or slowly can matter as much as the amount.

Dosage & duration

Circadin oral prolonged-release label for primary insomnia in adults 55+.

Circadin

Product label
Dose
2 mg orally
How often
Once daily, 1–2 hours before bedtime after food
How long
Up to 13 weeks

Product- and age-specific; not a general injectable or pediatric schedule.

Sources: 3

More quick facts
Main role
Sleep timing
Sources : 1 · 2
Form matters
Quick versus prolonged release
Sources : 1 · 2

Why people look into it

Timing, formulation and the morning after

The useful question is which sleep problem you want to address; a larger amount is not automatically better.

  • Sleep timing

    Jet lag, a delayed body clock and ongoing insomnia are different problems.

  • Release pattern

    Immediate-release products and prolonged-release tablets deliver melatonin differently.

  • Next-day function

    Sleepiness, headache and dizziness can affect whether it is useful for you.

Circadin’s evidence belongs to its specific oral product and population. It does not establish the benefit of an injectable sleep blend. Sources and context
In this guide

Match it to the sleep problem

Jet lag, a delayed body clock and ongoing insomnia are different problems. A routine that helps one may not help another. Persistent poor sleep deserves more than repeated dose increases.

Immediate versus prolonged release

Immediate-release products deliver melatonin differently from prolonged-release tablets such as Circadin. The example below belongs to that specific oral product and age group, not every gummy, tablet or injectable blend.

The trade-offs

Next-day sleepiness, headache and dizziness can occur. Supplement strength can vary, and long-term safety information is limited. The dose on a wellness blend is not evidence that its route improves sleep.

Dose references and context Existing reported protocols; not personal dosing instructions

This older catalog material includes research and community reports. It has not all been source-checked in this page update and should not be treated as a dosing recommendation.

Circadin EU label — primary insomnia age 55+

2 mg prolonged-release tablet · Oral · Once daily, 1–2 hours before bedtime after food · Up to 13 weeks

Product-specific label context; not interchangeable with immediate-release supplements or injections.

Why isn’t there a plot?

This informational entry has no supported pharmacokinetic model.

Common questions

Is more melatonin always better?

No. The timing, formulation and sleep problem affect usefulness; a larger dose can add unwanted sleepiness.

Does an oral melatonin study support a sleep injection?

No. It does not establish the effectiveness or safety of an injected blend.

Sources Labels, studies and notes behind this guide

Catalog evidence: Human clinical trials. This describes the type of evidence, not a clinical review of every claim.

Summary and fact source checks: 2026-10-07. This records source checking, not medical review of the whole page.

Notes on the quick facts

Main role
Timing and the type of sleep problem matter.
Form matters
The same mg amount need not produce the same pattern.
  • 1. EMA: Circadin assessment and product information

    2 mg prolonged-release oral product for short-term primary insomnia in adults 55+; after food 1–2 h before bedtime, up to 13 weeks. Product-specific, not every supplement or injection.

  • 2. NCCIH: melatonin evidence and safety

    Condition-specific evidence, timing, supplement variability and limited long-term safety information. Does not establish benefit for an injectable sleep blend.

  • 3. Circadin manufacturer SmPC

    Current oral prolonged-release medicine information inspected; does not validate an injected multi-ingredient sleep blend.

Related compounds and examples

Comments

Loading comments…